| Prevalence of cervical cancer screening among women aged 30-49 years (%) WHO | WHO | – |
| Crude suicide rates (per 100 000 population) WHO | WHO | – |
| Age-standardized suicide rates (per 100 000 population) WHO | WHO | – |
| Mortality rate attributed to unintentional poisoning (per 100 000 population) WHO | WHO | – |
| Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths WHO | WHO | – |
| Age-standardized NCD mortality rate (per 100 000 population) WHO | WHO | – |
| Total NCD Deaths WHO | WHO | – |
| Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease WHO | WHO | – |
| Adult mortality rate (probability of dying between 15 and 60 years per 1000 population) WHO | WHO | – |
| Number of female leprosy new cases WHO | WHO | – |
| New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population WHO | WHO | – |
| Number of non-autochthonous leprosy cases WHO | WHO | – |
| New leprosy case detection rate per 1 000 000 population WHO | WHO | – |
| Leprosy - Number of cases registered for treatment WHO | WHO | – |
| Leprosy registered prevalence rate per 1 000 000 population WHO | WHO | – |
| Number of new G2D leprosy cases WHO | WHO | – |
| Leprosy - New leprosy cases with G2D rate per 1 000 000 population WHO | WHO | – |
| Leprosy - Number of new leprosy cases among children (less than 15 years of age) WHO | WHO | – |
| Number of new leprosy cases with G2D among children (less than 15 years of age) WHO | WHO | – |
| Number of new leprosy cases WHO | WHO | – |
| Hepatitis - Deaths caused by chronic hepatitis B and C (per 100 000 population) WHO | WHO | – |
| People living with chronic hepatitis B (HBV) (number) WHO | WHO | – |
| Prevalence of chronic hepatitis B (HBV) in the general population (%) WHO | WHO | – |
| People living with chronic hepatitis C (HCV) including cured (all ages) (adjusted number) WHO | WHO | – |
| People living with chronic hepatitis C (HCV) (number) WHO | WHO | – |
| Prevalence of chronic hepatitis C (HCV) ) in the general population (%) WHO | WHO | – |
| Hepatitis - Deaths caused by chronic hepatitis B and C WHO | WHO | – |
| Chronic hepatitis C (HCV) infected persons diagnosed (number) WHO | WHO | – |
| Pregnant women attending antenatal care, tested for HBsAg (percent) WHO | WHO | – |
| Pregnant women attending antenatal care, tested positive for HBsAg (percent) WHO | WHO | – |
| Life expectancy at birth (years) WHO | WHO | – |
| Healthy life expectancy (HALE) at birth (years) WHO | WHO | – |
| Healthy life expectancy (HALE) at age 60 (years) WHO | WHO | – |
| Life expectancy at age 60 (years) WHO | WHO | – |
| Status of elimination of trachoma as a public health problem WHO | WHO | – |
| Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) WHO | WHO | – |
| Physical activity policies for activie societies WHO | WHO | – |
| Physical activity policies focused on active systems WHO | WHO | – |
| Overweight numbers among children under 5 years of age (thousands), model-based estimates WHO | WHO | – |
| Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates WHO | WHO | – |
| Stunting numbers among children under 5 years of age (millions), model-based estimates WHO | WHO | – |
| Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates WHO | WHO | – |
| Number of under-five deaths WHO | WHO | – |
| Under-five mortality rate (probability of dying by age 5 per 1000 live births) WHO | WHO | – |
| Stillbirth rate (per 1000 total births) WHO | WHO | – |
| Number of deaths among children ages 5 to 9 years WHO | WHO | – |
| Mortality rate among children ages 5 to 9 years (per 1000 children aged 5) WHO | WHO | – |
| Number of neonatal deaths WHO | WHO | – |
| Neonatal mortality rate (per 1000 live births) WHO | WHO | – |
| Number of deaths among children 5 to 14 years of age WHO | WHO | – |
| Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years) WHO | WHO | – |
| Number of women of reproductive age (aged 15-49 years) with anaemia (thousands) WHO | WHO | – |
| Number of infant deaths WHO | WHO | – |
| Infant mortality rate (probability of dying between birth and age 1 per 1000 live births) WHO | WHO | – |
| Number of deaths among adolescents (10 to 19 years of age) WHO | WHO | – |
| Adolescent mortality rate (per 1 000 age specific cohort) WHO | WHO | – |
| Hepatitis B surface antigen (HBsAg) prevalence (%) WHO | WHO | – |
| Childhood cancer survival for lymphoid leukaemia, age-standardized 5-year net survival (%) WHO | WHO | – |
| International Health Regulations core capacity scores, SPAR version, 2nd edition WHO | WHO | – |
| Reported number of human rabies deaths WHO | WHO | – |
| Polio (Pol3) immunization coverage among 1-year-olds (%) WHO | WHO | – |
| Pertussis - number of reported cases WHO | WHO | – |
| Total tetanus - number of reported cases WHO | WHO | – |
| Yellow fever - number of reported cases WHO | WHO | – |
| Rubella - number of reported cases WHO | WHO | – |
| Diphtheria - number of reported cases WHO | WHO | – |
| Japanese encephalitis - number of reported cases WHO | WHO | – |
| Mumps - number of reported cases WHO | WHO | – |
| Congenital Rubella Syndrome - number of reported cases WHO | WHO | – |
| Neonatal tetanus - number of reported cases WHO | WHO | – |
| Measles - number of reported cases WHO | WHO | – |
| Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%) WHO | WHO | – |
| Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%) WHO | WHO | – |
| Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%) WHO | WHO | – |
| Hib (Hib3) immunization coverage among 1-year-olds (%) WHO | WHO | – |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) WHO | WHO | – |
| Inactivated first-dose polio vaccine (IPV1) immunization coverage among 1-year-olds (%) (WUENIC) WHO | WHO | – |
| Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%) WHO | WHO | – |
| Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) WHO | WHO | – |
| BCG immunization coverage among 1-year-olds (%) WHO | WHO | – |
| Diphtheria tetanus toxoid and pertussis first-dose (DTP1) immunization coverage among 1-year-olds (%) (WUENIC) WHO | WHO | – |
| Adopted written national policy on alcohol WHO | WHO | – |
| Alcoholic beverage legally defined WHO | WHO | – |
| National legislation to prevent illegal alcohol WHO | WHO | – |
| Standard drink defined WHO | WHO | – |
| National drinking guidelines WHO | WHO | – |
| National legislation to prevent illegal alcohol sales WHO | WHO | – |
| Government monopoly on production WHO | WHO | – |
| Government monopoly on retail sales WHO | WHO | – |
| Detection of marketing infringements WHO | WHO | – |
| Penalties for marketing infringements WHO | WHO | – |
| Off-premise sales restrictions on days WHO | WHO | – |
| Off-premise sales restrictions on hours WHO | WHO | – |
| Off-premise sales restrictions on places WHO | WHO | – |
| Off-premise sales restrictions on outlet density WHO | WHO | – |
| On-premise sales restrictions on days WHO | WHO | – |
| On-premise sales restrictions on hours WHO | WHO | – |
| On-premise sales restrictions on places WHO | WHO | – |
| On-premise sales restrictions on outlet density WHO | WHO | – |
| On-premise sales restrictions to intoxicated persons WHO | WHO | – |
| Server training WHO | WHO | – |
| Advertising restrictions on national television WHO | WHO | – |
| Advertising restrictions on cable television WHO | WHO | – |
| Advertising restrictions on national radio WHO | WHO | – |
| Advertising restrictions on local radio WHO | WHO | – |
| Advertising restrictions in print media WHO | WHO | – |
| Advertising restrictions at cinemas WHO | WHO | – |
| Advertising restrictions on billboards WHO | WHO | – |
| Level of taxation adjusted for inflation WHO | WHO | – |
| Duty paid or excise stamp on alcohol container WHO | WHO | – |
| Number of standard alcoholic drinks displayed on containers WHO | WHO | – |
| Alcohol content displayed on containers WHO | WHO | – |
| Health warning labels on pregnancy WHO | WHO | – |
| Health warning labels on under-age drinking WHO | WHO | – |
| Health warning labels on drink-driving WHO | WHO | – |
| Health warning labels on alcohol advertising WHO | WHO | – |
| Health warning labels on alcohol containers WHO | WHO | – |
| Legal blood alcohol concentration (BAC) limits WHO | WHO | – |
| Age limits off-premise sales WHO | WHO | – |
| Random breath testing (RBT) use WHO | WHO | – |
| Penalties for drink driving WHO | WHO | – |
| Sobriety checkpoints WHO | WHO | – |
| Graduated licensing WHO | WHO | – |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), by beverage type WHO | WHO | – |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average WHO | WHO | – |
| Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol), three-year average WHO | WHO | – |
| Alcohol, tourist consumption (in litres of pure alcohol), three-year average WHO | WHO | – |
| Alcohol, consumption of pure alcohol by type of beverage (%) WHO | WHO | – |
| Cancer survival for those diagnosed with breast cancer, 5-year net survival (%) WHO | WHO | – |
| Household air pollution attributable deaths WHO | WHO | – |
| Household air pollution attributable DALYs WHO | WHO | – |
| Household air pollution attributable DALYs (per 100 000, age-standardized) WHO | WHO | – |
| Household air pollution attributable death rate (per 100 000 population, age-standardized) WHO | WHO | – |
| Ambient air pollution attributable deaths WHO | WHO | – |
| Ambient air pollution attributable death rate (per 100 000 population, age-standardized) WHO | WHO | – |
| Ambient air pollution attributable DALYs WHO | WHO | – |
| Ambient air pollution attributable DALYs (per 100 000 population, age-standardized) WHO | WHO | – |
| Joint effects of air pollution attributable deaths WHO | WHO | – |
| Household and ambient air pollution attributable DALYs (per 100 000 capita, age-standardized) WHO | WHO | – |
| Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized) WHO | WHO | – |
| Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2), three-year average WHO | WHO | – |
| Exclusive breastfeeding under six months (in thousands) WHO | WHO | – |
| Underweight among adults, BMI < 18.5 kg/m2 (age-standardized estimate) (%) WHO | WHO | – |
| Underweight among adults, BMI < 18.5 kg/m2 (crude estimate) (%) WHO | WHO | – |
| Overweight among adults, BMI ≥ 25 kg/m2 (age-standardized estimate) (%) WHO | WHO | – |
| Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) (%) WHO | WHO | – |
| Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) (%) WHO | WHO | – |
| Obesity among adults, BMI ≥ 30 kg/m2 (crude estimate) (%) WHO | WHO | – |
| Proportion of population with primary reliance on clean fuels and technologies for cooking (%) WHO | WHO | – |
| Births attended by skilled health personnel (%) WHO | WHO | – |
| Adolescent birth rate (per 1000 women) WHO | WHO | – |
| Medical doctors (per 10,000) WHO | WHO | – |
| Nursing and midwifery personnel (per 10,000) WHO | WHO | – |
| Dentists (per 10,000) WHO | WHO | – |
| Pharmacists (per 10,000) WHO | WHO | – |
| Reported number of people requiring interventions against NTDs WHO | WHO | – |
| Tobacco MPOWER Protect people: P2 smoke-free places, additional characteristics WHO | WHO | – |
| Tobacco Monitor: school-based national surveys, tobacco use, tobacco smoking, and cigarette smoking, prevalence WHO | WHO | – |
| Tobacco Monitor: school-based national surveys, smokeless tobacco or e-cigarettes, prevalence WHO | WHO | – |
| Tobacco Monitor: population-based national surveys, smokeless tobacco or e-cigarettes WHO | WHO | – |
| Tobacco Monitor: population-based national surveys, tobacco use and smoking, prevalence WHO | WHO | – |
| Tobacco Monitor: population-based national surveys, smokeless tobacco or e-cigarettes, prevalence WHO | WHO | – |
| Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N) WHO | WHO | – |
| Tobacco Monitor: population-based national surveys, tobacco use and smoking WHO | WHO | – |
| Tobacco Monitor: school-based national surveys, tobacco use and smoking WHO | WHO | – |
| Tobacco Monitor: school-based national surveys, smokeless tobacco or e-cigarettes WHO | WHO | – |
| Environmental and Occupational Health and Hygiene Professionals (number) WHO | WHO | – |
| Traditional and Complementary Medicine Professionals (number) WHO | WHO | – |
| Pharmacists (number) WHO | WHO | – |
| Pharmaceutical Technicians and Assistants (number) WHO | WHO | – |
| Dentists (number) WHO | WHO | – |
| Dental Prosthetic Technicians (number) WHO | WHO | – |
| Nursing and midwifery personnel (number) WHO | WHO | – |
| Nursing personnel (number) WHO | WHO | – |
| Midwifery personnel (number) WHO | WHO | – |
| Medical doctors (number) WHO | WHO | – |
| Generalist medical practitioners (number) WHO | WHO | – |
| Specialist medical practitioners (number) WHO | WHO | – |
| Medical doctors not further defined (number) WHO | WHO | – |
| Estimate of current cigarette smoking prevalence (%) (age-standardized) WHO | WHO | – |
| Number of current cigarette smokers, estimate WHO | WHO | – |
| Estimate of current tobacco smoking prevalence (%) (age-standardized rate) WHO | WHO | – |
| Estimate of current tobacco use prevalence (%) (age-standardized) WHO | WHO | – |
| Estimate of current cigarette smoking prevalence (%) WHO | WHO | – |
| Estimate of current tobacco smoking prevalence (%) WHO | WHO | – |
| Antenatal care attendees who were positive for syphilis (%), reported WHO | WHO | – |
| Total number of malaria cases (presumed + confirmed cases) WHO | WHO | – |
| Number of suspected malaria cases WHO | WHO | – |
| Number of malaria suspects examined by rapid diagnostic test (RDT) WHO | WHO | – |
| Number of malaria positive cases by rapid diagnostic test (RDT) WHO | WHO | – |
| Number of indigenous P. vivax malaria cases WHO | WHO | – |
| Number of presumed malaria cases WHO | WHO | – |
| Number of indigenous P. falciparum malaria cases WHO | WHO | – |
| Domestic Expenditure on Malaria WHO | WHO | – |
| Number of malaria suspects examined by microscopy WHO | WHO | – |
| Number of malaria positive cases by microscopy WHO | WHO | – |
| Number of people protected from malaria by indoor residual spraying (IRS) WHO | WHO | – |
| Number of indigenous malaria cases WHO | WHO | – |
| Number of confirmed malaria cases WHO | WHO | – |
| Number of malaria cases treated with any first line tx courses (including artemisinin-based combination therapies (ACTs)) WHO | WHO | – |
| Status of indigenous malaria cases WHO | WHO | – |
| Estimated malaria mortality rate (per 100 000 population) WHO | WHO | – |
| Estimated malaria incidence (per 1000 population at risk) WHO | WHO | – |
| Estimated number of malaria deaths WHO | WHO | – |
| Estimated number of malaria cases WHO | WHO | – |
| Sugar-content of beverage (g/100ml) WHO | WHO | – |
| Primary data availability for UHC Service Coverage Index (SDG 3.8.1) (%) WHO | WHO | – |
| UHC Service Coverage Index (SDG 3.8.1) WHO | WHO | – |
| UHC Service Coverage sub-index on service capacity and access WHO | WHO | – |
| UHC Service Coverage sub-index on infectious diseases WHO | WHO | – |
| UHC Service Coverage sub-index on noncommunicable diseases WHO | WHO | – |
| UHC Service Coverage sub-index on reproductive, maternal, newborn and child health WHO | WHO | – |
| Treatment success rate: XDR-TB cases WHO | WHO | – |
| Treatment success rate for patients treated for MDR-TB (%) WHO | WHO | – |
| Treatment success rate: new TB cases WHO | WHO | – |
| Treatment success rate: previously treated TB cases WHO | WHO | – |
| New cases tested for RR-/MDR-TB (%) WHO | WHO | – |
| Previously treated cases tested for RR-/MDR-TB (%) WHO | WHO | – |
| Cases started on MDR-TB treatment WHO | WHO | – |
| Confirmed cases of RR-/MDR-TB WHO | WHO | – |
| Tuberculosis - new and relapse cases WHO | WHO | – |
| Status of endemicity of cutaneous leishmaniasis WHO | WHO | – |
| Status of endemicity of visceral leishmaniasis WHO | WHO | – |
| Hypertension: diagnosis coverage among adults aged 30-79 with hypertension, age-standardized (%) WHO | WHO | – |
| Hypertension: diagnosis coverage among adults aged 30-79 with hypertension, crude (%) WHO | WHO | – |
| Hypertension among adults aged 30-79 years, prevalence, age-standardized WHO | WHO | – |
| Hypertension among adults aged 30-79 years, prevalence, crude WHO | WHO | – |
| Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%) WHO | WHO | – |
| Hypertension treatment coverage among adults aged 30-79 with hypertension, crude (%) WHO | WHO | – |
| Prevalence of diabetes, age-standardized WHO | WHO | – |
| Prevalence of diabetes, crude WHO | WHO | – |
| Diabetes treatment coverage, age-standardized WHO | WHO | – |
| Diabetes treatment coverage, crude WHO | WHO | – |
| Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%) WHO | WHO | – |
| Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate) WHO | WHO | – |
| Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate) WHO | WHO | – |
| Food safety IHR (%) WHO | WHO | – |
| Hospital beds (per 10 000 population) WHO | WHO | – |
| Antenatal care coverage - at least four visits (%) WHO | WHO | – |
| HIV tests performed where results were received by a person (testing volume), reported number WHO | WHO | – |
| Percentage of HIV-positive results returned to people in the calendar year WHO | WHO | – |
| Tobacco Enforce bans: E1 direct advertising WHO | WHO | – |
| Population with primary reliance on polluting fuels and technologies for cooking (in millions) WHO | WHO | – |
| Proportion of population with primary reliance on polluting fuels and technologies for cooking (%) WHO | WHO | – |
| Population with primary reliance on clean fuels and technologies for cooking (in millions) WHO | WHO | – |
| Tobacco MPOWER Protect people: P1 smoke-free places (national legislation) WHO | WHO | – |
| Tobacco Enforce bans: E2 indirect advertising WHO | WHO | – |
| Tobacco Enforce bans: E3 indirect advertising, additional bans WHO | WHO | – |
| Tobacco Warning: W1a cigarette packaging health warnings WHO | WHO | – |
| Tobacco Warning: W1b smoked tobacco packaging health warnings WHO | WHO | – |
| Tobacco Warning: W1c smokeless tobacco packaging health warnings WHO | WHO | – |
| Tobacco Warning: W2a cigarette packaging health warnings, other characteristics WHO | WHO | – |
| Tobacco Warning: W2b smoked tobacco packaging health warnings, other characteristics WHO | WHO | – |
| Tobacco Warning: W2c smokeless tobacco packaging health warnings, other characteristics WHO | WHO | – |
| Women accessing antenatal care (ANC) services who were tested for syphilis (%), reported WHO | WHO | – |
| Tobacco Warning: W3 anti-tobacco mass-media campaigns WHO | WHO | – |
| Tobacco Offer help: O1 Support for treatment of tobacco dependence / Availability of smoking cessation support WHO | WHO | – |
| Tobacco Offer help: O2 Availability of tobacco cessation medications WHO | WHO | – |
| Tobacco MPOWER: National tobacco control programmes (NTCP) WHO | WHO | – |
| Tobacco MPOWER overview: Monitor, Protect people, Offer help, Warn of dangers, Enforce bans, Raise taxes WHO | WHO | – |
| Status of yaws endemicity WHO | WHO | – |
| Status of endemicity of Buruli ulcer WHO | WHO | – |
| Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%) WHO | WHO | – |
| 15-19 years old, current drinkers (%) WHO | WHO | – |
| Heavy episodic drinking (youth 15 -19 years) past 30 days (%) WHO | WHO | – |
| Alcohol, heavy continuous drinkers, drinkers only, past year (%) WHO | WHO | – |
| Alcohol, 15-19 years heavy continuous drinkers, drinkers only, past year (%) WHO | WHO | – |
| Alcohol, 15-19 years heavy continuous drinkers past year (%) WHO | WHO | – |
| Alcohol, heavy continuous drinkers past year (%) WHO | WHO | – |
| Average daily intake in grams of alcohol, population (15+) WHO | WHO | – |
| Alcohol-attributable all-cause deaths (all ages), (number) WHO | WHO | – |
| Alcohol-attributable DALYs lost from all causes (all ages), (number) WHO | WHO | – |
| Alcohol-attributable DALYs per 100,000 people (age standardized) WHO | WHO | – |
| Women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (%) WHO | WHO | – |
| Hepatitis B surface antigen (HBsAG) carriers (per 100 000 population) WHO | WHO | – |
| Prevalence of anaemia in women of reproductive age (aged 15-49) (%) WHO | WHO | – |
| Maternal mortality ratio (per 100 000 live births) WHO | WHO | – |
| Number of maternal deaths WHO | WHO | – |
| Antenatal care coverage - at least one visit (percent) WHO | WHO | – |
| Physical activity policies focused on active people WHO | WHO | – |
| New or unknown treatment history cases: Pulmonary, bacteriologically confirmed WHO | WHO | – |
| Vision and eyecare: Effective refractive error coverage (eREC) (%) WHO | WHO | – |
| Household and ambient air pollution attributable DALYs WHO | WHO | – |
| Alcohol-attributable all-cause deaths per 100,000, age standardized WHO | WHO | – |
| Alcohol-attributable fractions (15+), cancer deaths WHO | WHO | – |
| Percent of all DALYs attributable to alcohol WHO | WHO | – |
| Liver cirrhosis, age-standardized death rates (15+), per 100,000 population WHO | WHO | – |
| Liver cirrhosis, alcohol-attributable, age-standardized death rates, per 100,000 population WHO | WHO | – |
| Cancer, alcohol-attributable, age-standardized death rates, per 100,000 population WHO | WHO | – |
| Alcohol-attributable fractions (15+), liver cirrhosis deaths (%) WHO | WHO | – |
| Alcohol-attributable fractions (15+), road traffic crash deaths (%) WHO | WHO | – |
| Alcohol-attributable fractions, all-cause deaths (%) WHO | WHO | – |
| Cancer, age-standardized death rates (15+), per 100,000 population WHO | WHO | – |
| Proportion of births delivered in a health facility (Facility births) (%) WHO | WHO | – |
| Alcohol, average daily intake in grams among drinkers, three-year average WHO | WHO | – |
| Alcohol, drinkers only per capita (15+) consumption in litres of pure alcohol, three-year average WHO | WHO | – |
| Alcohol, abstainers lifetime (%), age-standardized WHO | WHO | – |
| Alcohol, abstainers past 12 months (%), age-standardized WHO | WHO | – |
| Alcohol, consumers past 12 months (%), age-standardized WHO | WHO | – |
| Alcohol, former drinkers (%), age-standardized WHO | WHO | – |